Methylene blue benefits: Medical, anti-aging, and more
Methylene blue treats methemoglobinemia, a blood condition. Recently, methylene blue supplements have gained attention for their alleged cognitive and aging support benefits, but these uses require further research.
A chemist named Heinrich Caro initially developed methylene blue as a clothing dye. Scientists later examined the substance’s potential to treat cyanide poisoning and other health issues and discovered that it was a particularly effective treatment for methemoglobinemia.
This article looks at what methylene blue is, its uses and potential benefits, and the dosage and safety of the substance.
Methylene blue, also known as methylthioninium chloride, is a compound with a dark blue-green color. The chemist and textile manufacturer, Heinrich Caro, initially synthesized the substance as a clothing dye in 1876.
Later, scientists started exploring its potential clinical uses. They discovered that methylene blue has various properties and mechanisms of action that could influence biological functions in the body.
Despite the potential benefits of methylene blue, the medication can cause side effects that may be severe. These include serotonin syndrome in people taking certain medications and various central nervous system symptoms.
In
Researchers are also exploring several promising potential uses of methylene blue that scientists may be able to develop in the future.
The current wellness trend for taking methylene blue supplements is based on emerging research. There is no conclusive evidence that it has benefits for cognition and aging support. Because supplements are unregulated by the FDA, people may take doses that have adverse effects and do more harm than good.
The FDA has currently only approved methylene blue to treat methemoglobinemia.
Methemoglobinemia affects the structure of iron molecules in the blood, preventing oxygen from binding to them. As a result, the blood cannot transport enough oxygen throughout the body, which may
Researchers are investigating the potential of methylene blue as a treatment for Alzheimer’s disease and other neurodegenerative conditions. The medication may inhibit the buildup of an abnormal protein in the brain called tau that may contribute to cognitive decline.
Preclinical research also suggests that methylene blue could protect against Parkinson’s disease, optic nerve damage, and stroke.
More research is necessary to determine how safe and effective these emerging uses of methylene blue may be.
Researchers believe the antioxidative properties of methylene blue could help reduce the oxidative stress involved in aging and cell damage.
Antioxidants fight unstable molecules called free radicals in the body that can lead to oxidative damage. As a person ages, the accumulation of oxidative damage to their DNA, proteins, and lipids may affect how their cells work.
Researchers believe it may be possible to use methylene blue to help prevent some of the oxidative damage involved in aging, which could help treat age-related conditions like memory loss, neurodegeneration, and skin aging.
However, more large-scale clinical research in humans is necessary to determine whether methylene blue has significant benefits in supporting aging.
Although methylene blue has potential benefits as a pain-reliever, it may lead to serious side effects at certain doses. These include serotonin toxicity, or serotonin syndrome, a potentially life threatening condition. Research also suggests that methylene blue can damage brain cells.
More research into methylene blue’s pain relieving effects in humans is necessary.
Research suggests that combining methylene blue with a type of cancer treatment called photodynamic therapy could have anticancer benefits.
Photodynamic therapy uses a light-activated drug to destroy cancer cells. A 2023 review of human and animal studies suggests that photodynamic therapy with methylene blue may be effective against various types of cancer, including carcinoma, melanoma, and colorectal cancer.
More research is necessary to determine how safe and effective methylene blue may be as a cancer treatment.
A person should use methylene blue according to a doctor’s instructions, or under the supervision of a healthcare professional. There are potential side effects and a risk of health complications.
To treat methemoglobinemia, a healthcare professional will
If people choose to take methylene blue supplements, they must choose a pharmaceutical-grade product, which will have “USP” on the label. Follow the dosage instructions on the package label.
Methylene blue may increase the risk of serotonin syndrome for people who take medications that affect serotonin. These include the following types of antidepressants:
Methylene blue is available without a prescription, sometimes in the form of oral supplements. It is important to note that the FDA
Intravenous methylene blue to treat methemoglobinemia requires a prescription and should be administered by a healthcare professional.
A doctor may safely prescribe other forms of methylene blue for off-label uses.
Methylene blue can cause serious, sometimes life threatening, complications. A person should check with a doctor before starting any new medications or supplements and follow the doctor’s instructions.
Methylene blue is a medication that the FDA has approved to treat methemoglobinemia, a blood disorder that affects the blood’s ability to transport oxygen.
A doctor may sometimes use or prescribe the medication off-label to treat certain conditions, including vasoplegic syndrome and malaria.
Researchers are studying methylene blue as a potential treatment for various health conditions, including certain cancers and Alzheimer’s disease.
There are potential benefits and risks of methylene blue. A person should speak with a doctor about whether the medication is safe for them.